Biotest AG: Preliminary announcement of the publication of financial reports according to Articles 37v, 37w, 37y of the WpHG [the German Securities Act]
December 06, 2017 at 05:10 am EST
Share
DGAP Preliminary announcement financial reports: Biotest AG / Preliminary announcement on the disclosure of financial statements
Biotest AG: Preliminary announcement of the publication of financial reports according to Articles 37v, 37w, 37y of the WpHG [the German Securities Act]
06.12.2017 / 11:04
Preliminary announcement of the publication of financial reports according to Articles 37v, 37w, 37y of the WpHG [the German Securities Act] transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Biotest AG hereby announces that the following financial reports shall be
disclosed :
Report: Annual financial report
Date of disclosure / German: March 22, 2018
Date of disclosure / English: March 22, 2018
German: https://www.biotest.com/de/de/investor_relations/news_und_publikationen_/publikationen/geschaeftsberichte.cfm
English: https://www.biotest.com/de/en/investor_relations/news_and_publications/publications/annual_reports.cfm
Report: Annual financial report of the group
Date of disclosure / German: March 22, 2018
Date of disclosure / English: March 22, 2018
German: https://www.biotest.com/de/de/investor_relations/news_und_publikationen_/publikationen/geschaeftsberichte.cfm
English: https://www.biotest.com/de/en/investor_relations/news_and_publications/publications/annual_reports.cfm
Report: Financial report of the group (half-year/Q2)
Date of disclosure / German: August 14, 2018
Date of disclosure / English: August 14, 2018
German: https://www.biotest.com/de/de/investor_relations/news_und_publikationen_/publikationen/quartalsberichte.cfm
English: https://www.biotest.com/de/en/investor_relations/news_and_publications/publications/quarterly_reports.cfm
06.12.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology, and intensive care medicine. It develops, manufactures, and markets immunoglobulin, coagulation factors, and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.
Biotest AG: Preliminary announcement of the publication of financial reports according to Articles 37v, 37w, 37y of the WpHG [the German Securities Act]
BIOTEST AG 
